Breelyn A Wilky MD – FDA Inspection, Jun 25, 2026

Record Details

This FDA Inspection record concerns Breelyn A Wilky MD, with an inspection on June 25, 2026, issued by the Denver District Office, covering human drugs.

Company: Breelyn A Wilky MD
Inspection Date: June 25, 2026
Product Type: Human Drugs
Office: Denver District Office
Person: Theressa B. Smith (Issuing Officer)

View Company Profile

ID · 54b60ad1-f41d-4910-9b84-3d4883198d5f

Inspection Facts

Inspection number: 1323706
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate
21 CFR 50.20Consent not obtained, exceptions do not apply

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Breelyn A Wilky MD

FDA Inspection

Breelyn A Wilky MDJune 25, 2026